Dolominol a and B, Two New Neolignans from Dolomiaea Souliei (franch.) C.Shih

Man Yi,Fan-Cheng Meng,Shen-Yue Qu,Jing-Xin Mao,Guowei Wang,Mingxing Liu,Zhi-Hua Liao,Min Chen
DOI: https://doi.org/10.1080/14786419.2021.1897125
2022-01-01
Natural Product Research
Abstract:Abstract Two new neolignans, dolominol A (1) and dolominol B (2), together with 12 known lignans, erythro-(7S,8R)-guaiacyl-glycerol-β-O-4′-dihydroconiferyl ether (3), threo-(7R,8R)-1-(4-hydroxy-3-methoxyphenyl)-2-{4-[(E)-3-hydroxy-1-propenyl)]-2-methoxyphenoxy}-1,3-propanediol (4), (-)-dihydrodehydrodiconiferyl alcohol (5), (-)-massoniresinol (6), vladinol D (7), syringaresinol (8), prinsepiol (9), medioresinol (10), (+)-pinoresinol (11), 2α-guaicyl-4-oxo-6α-catechyl-3,7-dioxabicyclo [3.3.0]octane (12), cycloolivil (13), isolariciresinol (14) were isolated from Dolomiaea souliei (Franch.) C.Shih. Their structures were determined by UV, CD, HR-ESI-TOFMS, 1 D and 2 D NMR experiments. Their hepatoprotective effect against LPS-induced L-02 cells injury was also studied. Result revealed that compound 4 showed best protective effect on LPS-induced L-02 cells. Graphical Abstract
What problem does this paper attempt to address?